GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Purchase Of Investment

Waverley Pharma (TSXV:WAVE) Purchase Of Investment : C$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Purchase Of Investment?

Waverley Pharma's purchase of investment for the three months ended in Mar. 2024 was C$0.00 Mil. It means Waverley Pharma spent C$0.00 Mil on purchasing investments. Waverley Pharma's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Dec. 2023 ), Waverley Pharma spent the same money on purchasing investments in Mar. 2024 (C$0.00 Mil).

Waverley Pharma Purchase Of Investment Historical Data

The historical data trend for Waverley Pharma's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Purchase Of Investment Chart

Waverley Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial - - - - -

Waverley Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Waverley Pharma Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Waverley Pharma Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma (TSXV:WAVE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Purchase Of Investment
Comparable Companies
XCNQ:NIRV TSXV:SVS TSXV:VXL TSXV:PSYB XCNQ:CURE XCNQ:AGN XCNQ:CMND TSX:IPCI XCNQ:MOOD TSXV:MRVL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5GZ:Germany
Address
1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6
Website
https://www.waverleypharma.com
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.
Executives
Albert David Friesen 10% Security Holder, Director, Senior Officer